Adam Feuerstein wrote that Advaxis Inc.'s (Nasdaq: ADXS) market valuation was low compared with its peers. Shares of the biotechnology company surged $1.66 to close at $9.89.
Feuerstein says Advaxis market valuation low
January 27, 2015 at 16:13 PM EST